Avanos Medical, Inc. (AVNS): Price and Financial Metrics

Avanos Medical, Inc. (AVNS): $40.03

0.01 (+0.02%)

POWR Rating

Component Grades














  • AVNS scores best on the Growth dimension, with a Growth rank ahead of 91.88% of US stocks.
  • AVNS's strongest trending metric is Stability; it's been moving up over the last 200 days.
  • AVNS ranks lowest in Momentum; there it ranks in the 15th percentile.

AVNS Stock Summary

  • With a one year PEG ratio of 867.03, Avanos Medical Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.94% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.38 for Avanos Medical Inc; that's greater than it is for just 19.16% of US stocks.
  • With a year-over-year growth in debt of -23.54%, Avanos Medical Inc's debt growth rate surpasses just 18.64% of about US stocks.
  • Stocks that are quantitatively similar to AVNS, based on their financial statements, market capitalization, and price volatility, are XONE, PLUS, NEOG, HCCI, and BMI.
  • AVNS's SEC filings can be seen here. And to visit Avanos Medical Inc's official web site, go to avanos.com.

AVNS Stock Price Chart Interactive Chart >

Price chart for AVNS

AVNS Price/Volume Stats

Current price $40.03 52-week high $53.61
Prev. close $40.02 52-week low $27.09
Day low $39.95 Volume 190,900
Day high $40.40 Avg. volume 363,777
50-day MA $41.90 Dividend yield N/A
200-day MA $42.27 Market Cap 1.92B

Avanos Medical, Inc. (AVNS) Company Bio

Avanos Medical, Inc. (formerly Halyard Health) is focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. The company was founded in 2014 and is based in Alpharetta, Georgia.

AVNS Latest News Stream

Event/Time News Detail
Loading, please wait...

AVNS Latest Social Stream

Loading social stream, please wait...

View Full AVNS Social Stream

Latest AVNS News From Around the Web

Below are the latest news stories about Avanos Medical Inc that investors may wish to consider to help them evaluate AVNS as an investment opportunity.

Enteral Feeding Devices Market 2021 Is Booming Across the Globe by Top Leading Players Nestle SA, Danone ,B.Braun Melsungen AG ,Avanos Medical ,Cardinal Health,Inc , Moog,Inc

Enteral Feeding Devices Market report gives clear idea to the Healthcare industry in regard with what is already available in the market, what market anticipates, the competitive environment, and what to be get done to surpass the competitor. This market report serves a great purpose of better decision making and achieving competitive advantage. The report []

Jumbo News | June 12, 2021

JMP Securities Reiterates a Hold Rating on Avanos Medical (AVNS)

JMP Securities analyst David Turkaly reiterated a Hold rating on Avanos Medical (AVNS) on May 28. The companys shares closed last Monday at The post JMP Securities Reiterates a Hold Rating on Avanos Medical (AVNS) appeared first on Smarter Analyst .

Smarter Analyst | June 8, 2021

Here's Why You Should Hold on to Avanos (AVNS) Stock for Now

Investors continue to be optimistic about Avanos (AVNS), owing to its strong product line and focus on its R&D.

Yahoo | May 20, 2021

Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference

Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET

Yahoo | February 24, 2021

The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) Angion Biomedica Corp (NASDAQ: ANGN) Antares Pharma Inc (NASDAQ: ATRS) Applied Molecular Transport Inc. (NASDAQ: AMTI) Avanos Medical Inc (NYSE: AVNS) (reacted to its fourth-quarter results) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Cellular Biomedicine Group Inc (NASDAQ: CBMG) Cleveland BioLabs, Inc. (NASDAQ: CBLI) Endo International PLC (NASDAQ: ENDP) Immunome Inc (NASDAQ: IMNM) ( reacted to discovery of antibodies against coronavirus variants) Mereo BioPharma Group plc – ADR (NASDAQ: MREO) Nantkwest Inc (NASDAQ: NK) Onconova Therapeutics Inc (NASDAQ: ONTX) Processa Pharmaceuticals Inc (NASDAQ: PCSA) Prothena Corporation PLC (NASDAQ: PRTA) ...

Yahoo | February 19, 2021

Read More 'AVNS' Stories Here

AVNS Price Returns

1-mo 0.13%
3-mo -16.50%
6-mo -19.13%
1-year 37.99%
3-year -33.26%
5-year 25.96%
YTD -12.75%
2020 36.14%
2019 -24.76%
2018 -3.01%
2017 24.88%
2016 10.69%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8296 seconds.